Decreased GSK3β phosphorylation, which causes increased GSK3β activity in specific cellular locations, pathways, and circuits, promotes susceptibility to mood disorders, and GSK3β inhibition is therapeutic for mood disorders [55–57]. This evidence concerns the gene GSK3B and mood disorder.